Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

950 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19.
Saitoh H, Sakai-Tagawa Y, Nagasawa S, Torimitsu S, Kubota K, Hirata Y, Iwatsuki-Horimoto K, Motomura A, Ishii N, Okaba K, Horioka K, Abe H, Ikemura M, Rokutan H, Hinata M, Iwasaki A, Yasunaga Y, Nakajima M, Yamaguchi R, Tsuneya S, Kira K, Kobayashi S, Inokuchi G, Chiba F, Hoshioka Y, Mori A, Yamamoto I, Nakagawa K, Katano H, Iida S, Suzuki T, Akitomi S, Hasegawa I, Ushiku T, Yajima D, Iwase H, Makino Y, Kawaoka Y. Saitoh H, et al. Among authors: kawaoka y. Int J Infect Dis. 2023 Apr;129:103-109. doi: 10.1016/j.ijid.2023.01.046. Epub 2023 Feb 7. Int J Infect Dis. 2023. PMID: 36754229 Free PMC article.
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Kashima Y, Kikuchi T, Theiler J, Yotsuyanagi H, Suzuki Y, Korber B, Kawaoka Y. Uraki R, et al. Among authors: kawaoka y. Lancet Reg Health West Pac. 2023 May;34:100777. doi: 10.1016/j.lanwpc.2023.100777. Epub 2023 May 11. Lancet Reg Health West Pac. 2023. PMID: 37193320 Free PMC article. No abstract available.
Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Wilson N, Bobholz M, Vuyk WC, Wei W, Ries H, O'Connor DH, Friedrich TC, Sordillo EM, van Bakel H, Simon V, Kawaoka Y. Sakai-Tagawa Y, et al. Among authors: kawaoka y. J Med Virol. 2023 May;95(5):e28788. doi: 10.1002/jmv.28788. J Med Virol. 2023. PMID: 37212288
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination.
Yamamoto S, Yamayoshi S, Ito M, Sakai-Tagawa Y, Nakachi I, Baba R, Kamimoto S, Ogura T, Hagiwara S, Kato H, Nakajima H, Uwamino Y, Yagi K, Sugaya N, Nagai H, Saito M, Adachi E, Koga M, Tsutsumi T, Duong C, Okuda M, Murakami J, Furusawa Y, Ujie M, Iwatsuki-Horimoto K, Yotsuyanagi H, Kawaoka Y. Yamamoto S, et al. Among authors: kawaoka y. iScience. 2023 Jun 25;26(7):107208. doi: 10.1016/j.isci.2023.107208. eCollection 2023 Jul 21. iScience. 2023. PMID: 37448563 Free PMC article.
Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine.
Kingstad-Bakke B, Cleven T, Bussan H, Yount BL Jr, Uraki R, Iwatsuki-Horimoto K, Koga M, Yamamoto S, Yotsuyanagi H, Park H, Mishra JS, Kumar S, Baric RS, Halfmann PJ, Kawaoka Y, Suresh M. Kingstad-Bakke B, et al. Among authors: kawaoka y. JCI Insight. 2023 Nov 22;8(22):e172510. doi: 10.1172/jci.insight.172510. JCI Insight. 2023. PMID: 37796612 Free PMC article.
Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.
Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T, Inoue M, Sakai-Tagawa Y, Ito M, Yamayoshi S, Iwatsuki-Horimoto K, Suzuki Y, Kawaoka Y. Hagihara M, et al. Among authors: kawaoka y. Intern Med. 2024 Jan 2. doi: 10.2169/internalmedicine.2900-23. Online ahead of print. Intern Med. 2024. PMID: 38171874 Free article.
Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.
Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Iwatsuki-Horimoto K, Yamayoshi S, Suzuki Y, Kawaoka Y, Ohmagari N. Maruki T, et al. Among authors: kawaoka y. J Infect Chemother. 2024 Jan 17:S1341-321X(24)00012-6. doi: 10.1016/j.jiac.2024.01.008. Online ahead of print. J Infect Chemother. 2024. PMID: 38242284 Free article.
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
Yamayoshi S, Nagai E, Mitamura K, Hagihara M, Kobayashi R, Takahashi S, Shibata A, Uwamino Y, Hasegawa N, Iqbal A, Kamimaki I, Iwatsuki-Horimoto K, Nagamura-Inoue T, Kawaoka Y. Yamayoshi S, et al. Among authors: kawaoka y. Epidemiol Infect. 2024 Jan 23;152:e24. doi: 10.1017/S0950268824000141. Epidemiol Infect. 2024. PMID: 38258464 Free PMC article.
950 results